Legacy Emanuel Hospital & Health Center

Legacy Emanuel Hospital & Health Center, a Portland, Oregon-based nonprofit hospital and tax-exempt corporate entity, acts primarily as a federal grant recipient and subrecipient in biomedical research and clinical studies, with secondary exposure to federal healthcare contracts routed through subsidiary Legacy Laboratory Services. The organization holds no federal prime contracts but participates as a subrecipient on research awards from the National Institutes of Health and related agencies, with legacy engagement on federal emergency management and correctional healthcare work.

The institution's federal footprint splits between prime grant work (63% of recent awards) and subrecipient arrangements (37%). Across the 179 recent awards spanning multiple years, Legacy Emanuel operates primarily as a research performer, not a service contractor. The National Institutes of Health dominates its customer base — the National Eye Institute alone funds 23 awards, and NIH broadly accounts for 26 awards across the portfolio. The Federal Emergency Management Agency anchors 34 awards, though many reflect historical COVID-era emergency management work rather than ongoing research programs. The Department of Justice Bureau of Prisons Federal Correctional Institution Sheridan drives the largest single dollar concentration ($1.4 million combined potential value across 20 awards), though this represents a smaller operational footprint than the NIH-driven research volume. Five agencies account for 63% of award count.

Legacy Emanuel's capability portfolio centers on vision research, neuroscience, and clinical epidemiology, grounded in the work of the Legacy Research Institute (a subsidiary structure housing ophthalmology and neurobiological laboratories). Recent prime grant recipients include the National Eye Institute's $702,487 award (September 2026, CFDA 93.867) to investigate pulsatility in retinal and optic nerve head blood flow in glaucomatous disease through September 2030; a National Eye Institute award for myopia research using tree shrew models and spatial protein profiling; a National Institute of Neurological Disorders and Stroke award (July 2024, through June 2029) examining circadian regulation of parvalbumin and perineuronal net function in memory retrieval; and a National Eye Institute award for lipid nanoparticle optimization in retinal gene editing. Legacy Emanuel also received a Bureau of Health Professionals grant (January 2022, through December 2025) on promoting mental health resilience among health professional workforces. In its subrecipient role, the organization contributes specialized research capabilities to prime recipients including The University of California San Francisco (psilocybin safety and adverse-outcome surveillance), The University of California Davis (retinal ganglion cell structure and function assessment), The University of Michigan (psychedelic use patterns and health impacts), The Ohio State University (circadian clock regulation in cortico-limbic circuits), Indiana University (retinal ganglion cell transplantation in experimental glaucoma models), The Washington University (vision-related quality of life in the Ocular Hypertension Treatment Study), and Oregon Health & Science University (pediatric transformation and psilocybin research programs).

Recent award volume has contracted — five awards in 2022, forty in 2023 (likely reflecting retroactive COVID-emergency management grants), twelve in 2024, and six each in 2025 and 2026. Combined potential value across all awards stands at $3.7 million, though obligated dollars total $100.4 million, reflecting substantial prior-year commitments. Three awards face ultimate completion within the next twenty-four months, presenting limited near-term recompete exposure. The top parent vehicles include a Department of Justice Blanket Purchase Agreement (DJBP0612BPA12009) with 14 task orders ($1.1 million combined potential value) and correctional-healthcare-related IDIQs. Legacy Laboratory Services, LLC, a subsidiary, carries the Reference Laboratory Testing designation (20 awards), suggesting pathology and clinical diagnostic work bundled under the parent organization. Legacy Emanuel also operates Life Flight Network LLC, a non-profit business entity not directly visible in the federal award footprint presented here. The organization's NAICS concentration reflects its hospital identity — General Medical and Surgical Hospitals (24 awards), Medical Laboratories (20 awards), and Offices of Physicians (7 awards) dominate the category mix.